During the past decade, CH de MACON conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de MACON" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 5 trials, followed by "Federation Francophone de Cancerologie Digestive" with 4 trials sponsored, "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "Centre Hospitalier Universitaire Dijon" with 2 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de MACON" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator and "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "CH de MACON" are "Colorectal Cancer" (2 trials), "Adenocarcinoma of Lung Metastatic to Brain" (1 trials), "Advanced Cancer" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials) and "Ampullary Adenocarcinoma" (1 trials). Many other conditions were trialed in "CH de MACON" in a lesser frequency.

Most popular intervention types in "CH de MACON" are "Drug" (16 trials), "Other" (7 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (3 trials), "Bevacizumab" (2 trials), "Cisplatin" (2 trials), "Gemcitabine" (2 trials) and "1 year follow-up to assess psychiatric morbidity" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH de MACON" are 29 trials for "All" genders.

Currently, there are NaN active trials in "CH de MACON". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in CH de MACON, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CH de MACON, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".